Improving therapeutic approaches for patients with Ph-like ALL & the importance of disease biology
Sarah Tasian • 16 Apr 2023
Gilteritinib and CAR T-cell therapy in high-risk pediatric leukemias
Sarah Tasian • 13 Dec 2021
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter